EP Patent

EP0434094B1 — Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppresants and vasodilators

Assigned to GD Searle LLC · Expires 1993-03-31 · 33y expired

What this patent protects

Substituted 2-isopropyl-2-phenyl-5-(phenethyl amino) valeronitriles are used as immunosuppressors in a method of treatment of organ transplant rejection, either alone or concurrently with administration of cyclosporin in a synergistic manner that permits lowered dosages of cyclos…

USPTO Abstract

Substituted 2-isopropyl-2-phenyl-5-(phenethyl amino) valeronitriles are used as immunosuppressors in a method of treatment of organ transplant rejection, either alone or concurrently with administration of cyclosporin in a synergistic manner that permits lowered dosages of cyclosporin than if cyclosporin were to be administered alone. The mechanism of action is thought to be independent of cardiovascular calcium channel blocking activity of the compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP0434094B1
Jurisdiction
EP
Classification
Expires
1993-03-31
Drug substance claim
No
Drug product claim
No
Assignee
GD Searle LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.